These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15836544)

  • 1. Ambulatory hypercholesterolemia management in patients with atherosclerosis. Gender and race differences in processes and outcomes.
    Persell SD; Maviglia SM; Bates DW; Ayanian JZ
    J Gen Intern Med; 2005 Feb; 20(2):123-30. PubMed ID: 15836544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia prevalence, awareness, and treatment in blacks and whites: the Minnesota Heart Survey.
    Sprafka JM; Burke GL; Folsom AR; Hahn LP
    Prev Med; 1989 Jul; 18(4):423-32. PubMed ID: 2798366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control.
    Turner BJ; Hollenbeak CS; Weiner M; Tang SS
    BMC Cardiovasc Disord; 2011 Sep; 11():58. PubMed ID: 21961563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines.
    Maviglia SM; Teich JM; Fiskio J; Bates DW
    J Gen Intern Med; 2001 Aug; 16(8):531-7. PubMed ID: 11556929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project.
    Keyserling TC; Ammerman AS; Davis CE; Mok MC; Garrett J; Simpson R
    Arch Fam Med; 1997; 6(2):135-45. PubMed ID: 9075448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol.
    Goldberg KC; Melnyk SD; Simel DL
    Am J Manag Care; 2007 Sep; 13(9):530-4. PubMed ID: 17803367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
    Nanna MG; Navar AM; Zakroysky P; Xiang Q; Goldberg AC; Robinson J; Roger VL; Virani SS; Wilson PWF; Elassal J; Lee LV; Wang TY; Peterson ED
    JAMA Cardiol; 2018 Aug; 3(8):739-748. PubMed ID: 29898219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid lowering in a multidisciplinary clinic compared with primary physician management.
    Harris DE; Record NB; Gipson GW; Pearson TA
    Am J Cardiol; 1998 Apr; 81(7):929-33. PubMed ID: 9555787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of adequate control of increased serum low-density lipoprotein cholesterol in self-pay or Medicare patients versus Medicaid or private insurance patients followed in a University General Medicine Clinic.
    Varma R; Aronow WS; Gandelman G; Zammit C
    Am J Cardiol; 2005 Jan; 95(2):269-70. PubMed ID: 15642567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultural competency training and performance reports to improve diabetes care for black patients: a cluster randomized, controlled trial.
    Sequist TD; Fitzmaurice GM; Marshall R; Shaykevich S; Marston A; Safran DG; Ayanian JZ
    Ann Intern Med; 2010 Jan; 152(1):40-6. PubMed ID: 20048271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care.
    Cook NL; Ayanian JZ; Orav EJ; Hicks LS
    Circulation; 2009 May; 119(18):2463-70. PubMed ID: 19398667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differentials in the identification of hypercholesterolemia.
    Naumburg EH; Franks P; Bell B; Gold M; Engerman J
    J Fam Pract; 1993 Apr; 36(4):425-30. PubMed ID: 8463785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.
    Egan BM; Li J; Qanungo S; Wolfman TE
    Circulation; 2013 Jul; 128(1):29-41. PubMed ID: 23817481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Gazzara RA; Brady WE; Palmisano J
    Mayo Clin Proc; 2006 Sep; 81(9):1177-85. PubMed ID: 16970214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
    Gamboa CM; Colantonio LD; Brown TM; Carson AP; Safford MM
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors.
    Krobot KJ; Yin DD; Alemao E; Steinhagen-Thiessen E
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):37-45. PubMed ID: 15703504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.